Proportion (%) of participants achieving goal at baseline | Proportion (%) of participants achieving goal after intervention | Change (endpoint baseline) (%) | Adjusted OR (95% CI)* | P value | ||||||
Intervention | Control | P value† | Intervention | Control | P value† | Intervention | Control | |||
HbA1c <7% | 37.1 | 40.7 | 0.244 | 55.0 | 47.5 | 0.015 | 17.9 | 6.8 | 1.94 (1.35 to 2.81) | <0.001 |
BMI <24 kg/m2 | 39.3 | 39.7 | 0.940 | 44.7 | 40.2 | 0.147 | 5.4 | 0.5 | 1.79 (1.13 to 2.85) | 0.013 |
FPG <7.0 mmol/L | 45.5 | 44.6 | 0.810 | 51.9 | 44.2 | 0.012 | 6.4 | −0.4 | 1.70 (1.20 to 2.39) | 0.002 |
BP <140/80 mm Hg | 43.6 | 34.3 | 0.002 | 43.4 | 34.7 | 0.004 | −0.2 | 0.4 | 1.34 (0.97 to 1.85) | 0.079 |
Triglyceride <1.7 mmol/L | 64.5 | 60.6 | 0.202 | 66.5 | 56.2 | <0.001 | 2.0 | −4.4 | 1.57 (1.03 to 2.40) | 0.036 |
HDL (>1.0 mmol/L for men and >1.3 mmol/L for women) | 62.9 | 66.8 | 0.196 | 73.9 | 69.6 | 0.128 | 11.0 | 2.8 | 1.74 (1.15 to 2.62) | 0.008 |
LDL <2.6 mmol/L | 43.5 | 34.3 | 0.002 | 43.6 | 34.2 | 0.002 | 0.1 | −0.1 | 1.32 (0.93 to 1.87) | 0.122 |
Total cholesterol <4.5 mmol/L | 40.6 | 32.8 | 0.008 | 44.3 | 36.7 | 0.012 | 3.7 | 3.9 | 1.23 (0.88 to 1.72) | 0.225 |
*OR and 95% CI, estimated with mixed-effects models, presents the likelihood of achieving target goal among intervention participants compared with control participants at study end.
†χ2 tests for categorical variables between intervention and control groups.
BMI, body mass index; BP, blood pressure; FPG, fasting plasma glucose; HDL, high-density lipoprotein; LDL, low-density lipoprotein.